Role for calcium-activated potassium channels (BK) in migration control of human hepatocellular carcinoma cells

J Cell Mol Med. 2021 Oct;25(20):9685-9696. doi: 10.1111/jcmm.16918. Epub 2021 Sep 12.

Abstract

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. Its high metastasis rate is significantly correlated with poor patient prognosis. Elucidating the molecular mechanism underlying HCC metastasis is essential for HCC treatment. Owing to their high conductance, large-conductance calcium-activated potassium channels (BK channels) play a critical role in the control of membrane potential and have repeatedly been proposed as potential targets for cancer therapy. Emerging evidence suggests that BK channels are involved in the progression of cancer malignancies. The present study investigated the role of BK channels in mediating the hypoxia-stimulated migration of HCC cells both in vitro and in vivo in the absence and presence of various BK channels modulators. We found that BK channels were functionally expressed on the membranes of the SMMC-7721 and Huh7 HCC cell lines. Furthermore, blockage or activation of BK channels on the surface of HCC cells correspondingly inhibited or promoted HCC cell proliferation, migration and invasion in hypoxia conditions, with altered expression and distribution of cell-cell adhesion molecule E-cadherin and typical marker of mesenchymal cells, Vimentin, but not N-cadherin. Hypoxia conditions did not alter BK channels expression but increased its open probability. Moreover, BK channels blocker IbTX significantly inhibited HCC cell remote colonization in HCC cell xenografted mice. In conclusion, the results of this study suggest that blocking BK channels offers an attractive strategy for treating HCC.

Keywords: BK channels; hepatocellular carcinoma; migration; proliferation; xenografted mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carcinoma, Hepatocellular / genetics
  • Carcinoma, Hepatocellular / metabolism
  • Carcinoma, Hepatocellular / pathology
  • Cell Cycle / genetics
  • Cell Line, Tumor
  • Cell Movement / genetics*
  • Cell Proliferation / drug effects
  • Disease Models, Animal
  • Electrophysiological Phenomena
  • Heterografts
  • Humans
  • Ion Channel Gating / drug effects
  • Ion Channel Gating / genetics
  • Liver Neoplasms / genetics
  • Liver Neoplasms / metabolism
  • Liver Neoplasms / pathology
  • Mice
  • Potassium Channel Blockers / pharmacology
  • Potassium Channels, Calcium-Activated / genetics*
  • Potassium Channels, Calcium-Activated / metabolism*
  • Xenograft Model Antitumor Assays

Substances

  • Potassium Channel Blockers
  • Potassium Channels, Calcium-Activated